A Consensus Set of Outcomes for Parkinson’s Disease from the International Consortium for Health Outcomes Measurement

Background: Parkinson’s disease (PD) is a progressive neurodegenerative condition that is expected to double in prevalence due to demographic shifts. Value-based healthcare is a proposed strategy to improve outcomes and decrease costs. To move towards an actual value-based health care system, condition-specific outcomes that are meaningful to patients are essential. Objective: Propose a global consensus standard set of outcome measures for PD.

Methods: Established methods for outcome measure development were applied, as outlined and used previously by the International Consortium for Health Outcomes Measurement (ICHOM). An international group, representing both patients and experts from the fields of neurology, psychiatry, nursing, and existing outcome measurement efforts, was convened. The group participated in six teleconferences over a six-month period, reviewed existing data and practices, and ultimately proposed a standard set of measures by which patients should be tracked, and how often data should be collected.

Results: The standard set applies to all cases of idiopathic PD, and includes assessments of motor and non-motor symptoms, ability to work, PD-related health status, and hospital admissions. Baseline demographic and clinical variables are included to enable case mix adjustment.

Conclusions: The Standard Set is now ready for use and pilot testing in the clinical setting. Ultimately, we believe that using the set of outcomes proposed here will allow clinicians and scientists across the world to document, report, and compare PD-related outcomes in a standardized fashion. Such international benchmarks will improve our understanding of the disease course and allow for identification of ‘best practices’, ultimately leading to better informed treatment decisions.

Contributors

The ICHOM Standard Set for Parkinson’s Disease was developed in partnership with ICHOM, under the leadership of Professor Ryan Uitti, Department of Neurology at the Mayo Clinic.

Publication

Journal: Journal of Parkinson’s Disease
Volume: 7
Issue:
Pages: 533 - 543
Year: 2017
DOI: http://www.ichom.org/project/parkinsons-disease/

Further Study Information

Current Stage: Not Applicable
Date:
Funding source(s): Not stated


Health Area

Disease Category: Neurology

Disease Name: Parkinson's disease

Target Population

Age Range: 18 - 100

Sex: Either

Nature of Intervention: Behavioural , Drug, Exercise, Other, Injection , Procedure

Stakeholders Involved

- Clinical experts
- Other
- Patient/ support group representatives

Study Type

- COS for practice

Method(s)

- Other
- Delphi process
- Interview
- Literature review

Other: Working group

Linked Studies

    No related studies


Related Links

    No related links